Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis

Heart, Artery and Coronary DiseasesTherapy and Intervention

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

J Am Coll Cardiol

Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Crouch J, Merhi W, Wai Sang SL, Kleiman NS, Petrossian G, Robinson NB, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick EM, Saito S, Oh JK, Jung Y, Reardon MJ, Low Risk Trial Investigators

doi: 10.1016/j.jacc.2025.03.004

Heart, Artery and Coronary DiseasesTherapy and Intervention

Prognostic Value of Myocardial CT-ECV in Severe Aortic Stenosis Requiring Aortic Valve Replacement: A Systematic Review and Meta-analysis

Eur Heart J Cardiovasc Imaging

Faggiano A, Gherbesi E, Carugo S, Brusamolino M, Cozac DA, Cozza E, Savo MT, Cannata F, Guglielmo M, La Mura L, Fazzari F, Carrabba N, Conte E, Mushtaq S, Baggiano A, Guaricci AI, Pedrinelli R, Indolfi C, Sinagra G, Perrone Filardi P, Pergola V, Pontone G

doi: 10.1093/ehjci/jeae324

Heart, Artery and Coronary DiseasesFurther Publications

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Clin Res Cardiol

Saad M, Seoudy H, Bramlage K, Bramlage P, Voran JC, Puehler T, Lutter G, Allali A, Landt M, Frank J, Bisht O, Salem M, Wienemann H, Adam M, Zeus T, Veulemans V, Bleiziffer S, Rudolph TK, Frank D

doi: 10.1007/s00392-025-02611-w

Heart, Artery and Coronary DiseasesTherapy and Intervention

ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial

Lancet

Makkar RR, Ramana RK, Gnall E, Ramlawi B, Cheng W, Diamantouros P, Potluri S, Kleinman N, Gupta A, Chakravarty T, Samy S, Rassi A, Rajagopal V, Yakubov S, Sorajja P, Patel D, Garcia S, Yadav P, Thourani V, Wang J, Rinaldi M, Kapadia S, Waksman R, Webb J, Ren CB, Gregson J, Modolo R, Sathananthan J, Reardon MJ, ACURATE IDE study investigators

doi: 10.1016/S0140-6736(25)00319-8

Heart, Artery and Coronary Diseases

Grading of Aortic Valve Calcification Severity and Risk Stratification in Aortic Stenosis

J Am Heart Assoc

Tastet L, Ali M, Pibarot P, Capoulade R, Øvrehus KA, Arsenault M, Haujir A, Bédard É, Diederichsen ACP, Dahl JS, Clavel MA

doi: 10.1161/JAHA.123.035605

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Moderate or Severe Mitral and Tricuspid Valves Regurgitation after Transcatheter Aortic Valve Replacement

Am Heart J

Abraham B, Suppah M, Farina J, Botros M, Fath A, Kaldas S, Megaly M, Chao CJ, Arsanjani R, Ayoub C, Fortuin FD, Sweeney J, Pellikka P, Nkomo V, Alkhouli M, Holmes D Jr, Badr A, Alsidawi S

doi: 10.1016/j.ahj.2024.11.003

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Aortic Stenosis and Cardiogenic Shock

Eur Heart J Acute Cardiovasc Care

Ismayl M, Ahmed H, Goldsweig AM, Eleid MF, Guerrero M, Rihal CS

doi: 10.1093/ehjacc/zuae103

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves

JACC Cardiovasc Interv

Zahr F, Elmariah S, Vemulapalli S, Kodali SK, Hahn RT, Anderson AS, Eleid MF, Davidson CJ, Sharma RP, O'Neill WW, Bethea B, Thourani VH, Chakravarty T, Gupta A, Makkar RR

doi: 10.1016/j.jcin.2024.07.005

Heart, Artery and Coronary DiseasesTherapy and Intervention

Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial

Circulation

Lindman BR, Pibarot P, Schwartz A, Oldemeyer JB, Su YR, Goel K, Cohen DJ, Fearon WF, Babaliaros V, Daniels D, Chhatriwalla A, Suradi HS, Shah P, Szerlip M, Mack MJ, Dahle T, O'Neill WW, Davidson CJ, Makkar R, Sheth T, Depta J, DeVries JT, Southard J, Pop A, Sorajja P, Hahn RT, Zhao Y, Leon MB, Généreux P, EARLY TAVR Trial Executive Committee and Study Investigators

doi: 10.1161/CIRCULATIONAHA.125.074425

Related content

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

Prognostic Value of Myocardial CT-ECV in Severe Aortic Stenosis Requiring Aortic Valve Replacement: A Systematic Review and Meta-analysis

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial

Grading of Aortic Valve Calcification Severity and Risk Stratification in Aortic Stenosis

Impact of Moderate or Severe Mitral and Tricuspid Valves Regurgitation after Transcatheter Aortic Valve Replacement

Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Aortic Stenosis and Cardiogenic Shock

Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves

Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial